Randomized phase II trial of TS-1 [S 1] monotherapy versus TS-1 plus gemcitabine therapy in patients with gemcitabine-resistant advanced pancreatic cancer
Latest Information Update: 10 May 2017
At a glance
- Drugs Gemcitabine (Primary) ; Gimeracil/oteracil/tegafur (Primary)
- Indications Pancreatic cancer
- Focus Therapeutic Use
- Acronyms KCGCOR-1
- 08 May 2008 New trial record.